Vorsitz: A. Elsässer (Oldenburg), E. Giannitsis (Heidelberg)
| (V662) | Midregional pro-atrial natriuretic peptide in patients with suspected acute coronary syndrome |
|
|
S. Tzikas, T. Keller, T. Zeller, F. Ojeda Echevarria, E. Czyz, P. S. Wild, C. Bickel, S. Baldus, R. Schnabel, E. Lubos, J. Kunde, O. Hartmann, A. Bergmann, K. J. Lackner, S. Genth-Zotz, T. Münzel, S. Blankenberg (Mainz, Koblenz, Hamburg, Henningsdorf) |
| (V663) | Follistatin-Like 1 for Risk Prediction in Acute Coronary Syndrome |
|
|
C. Widera, T. Kempf, K. Bethmann, H. A. Katus, E. Giannitsis, K. C. Wollert (Hannover, Heidelberg) |
| (V664) | Circulating CD31+/Annexin V+ Apoptotic Endothelial Microparticles and Cardiovascular Outcomes. |
|
|
J.-M. Sinning, J. Losch, K. Walenta, M. Böhm, G. Nickenig, N. Werner (Bonn, Homburg/Saar) |
| (V665) | Circulating Factor Seven Activating Protease (FSAP) is associated with clinical outcome in acute coronary syndrome |
|
|
M. Parahuleva, A. Erdogan, O. Doerr, B. Parviz, H. Hoelschermann, H.-H. Tillmanns, S. M. Kanse (Gießen, Bad Homburg v.d. Höhe) |
| (V666) | Alzheimer’s disease-associated amyloid beta peptides 1-40 and 1-42 in patients with coronary artery disease |
|
|
K. Stellos, D. Stakos, K. Sopova, V. Panagiota, C. Gotsis, H. Alkhalil, B. Bigalke, M. Gawaz (Tübingen) |
| (V667) | In Vivo Markers of Oxidative Stress Predict CHD Independently of Traditional Risk Factors, Inflammatory Markers and Markers of Endothelial Dysfunction: Results from the MONICA/KORA Augsburg Study |
|
|
W. Koenig, M. Karakas, C. Herder, J. Baumert, C. Meisinger, B. Thorand (Ulm, Düsseldorf, Neuherberg) |